(Q37414437)

20 August 2017

Insulin-like growth factor II mediates resveratrol stimulatory effect on cathepsin D in breast cancer cells (English)

1 reference

20 August 2017

1 reference

1 reference

Sharda Vyas

1

1 reference

20 August 2017

Yayesh Asmerom

series ordinal

2

1 reference

20 August 2017

Daisy D De León

series ordinal

3

1 reference

20 August 2017

1 March 2006

1 reference

20 August 2017

Growth Factors Journal

1 reference

20 August 2017

24

1 reference

20 August 2017

1

1 reference

20 August 2017

79-87

1 reference

Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Molecular mechanism of the chemopreventive effect of resveratrol

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Cancer chemopreventive activity of resveratrol.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

The third IGF‐II promoter specifies transcription of three transcripts out of five in human placenta

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Resveratrol regulates insulin-like growth factor-II in breast cancer cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Modulation of cathepsin D routing by IGF-II involves IGF-II binding to IGF-II/M6P receptor in MCF-7 breast cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Estrogenic effects of resveratrol in breast cancer cells expressing mutant and wild-type estrogen receptors: role of AF-1 and AF-2.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Potent inhibitory action of red wine polyphenols on human breast cancer cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Promoter usage for insulin-like growth factor-II in cancerous and benign human breast, prostate, and bladder tissues, and confirmation of a 10th exon

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Antiproliferative effect of synthetic resveratrol on human breast epithelial cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Upstream stimulatory factors mediate estrogen receptor activation of the cathepsin D promoter

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

43 Cathepsin D from porcine and bovine spleen

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2774403

Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism.

26 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F08977190500366068

Axillary lymph node involvement in hormone-independent breast carcinomas

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1080%2F08977190500366068

Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis

21 January 2018

1 reference

12 December 2020

Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II

1 reference

12 December 2020

Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal

1 reference

12 December 2020

Quantification of insulin-like growth factor I (IGF-I) without interference by IGF binding proteins

1 reference

12 December 2020

Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism

1 reference

12 December 2020

Proteolysis of Insulin-Like Growth Factors (IGF) and IGF Binding Proteins by Cathepsin D1

1 reference

12 December 2020

Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II)

1 reference

12 December 2020

10.1080/08977190500366068

Identifiers

DOI

1 reference

20 August 2017

1 reference

20 August 2017

PubMed publication ID

16393696

1 reference